DFIB Cardiac Science (MM)

Cardiac Science Ranked Fourth Fastest Growing Technology Company in North America on the Deloitte Technology Fast 500 Program Revenue Growth Attributed to Entry Into AED Market IRVINE, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Cardiac Science Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic public access defibrillators (AEDs), today announced that it ranked No. 4 on the 2004 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America. Rankings are based on percentage revenue growth over five years, from 1999-2003. Cardiac Science grew 60,077 percent during this period. Cardiac Science's Chairman & CEO Raymond W. Cohen credits the Cardiac Science employees, partners and distributors with combining forces and establishing the Powerheart(R) brand as a leading choice in AEDs. He said, "Our strategic decision to enter the public access AED market came at a pivotal time as growth in that segment began to accelerate." "Growing the top line enough to make the Deloitte Technology Fast 500 is especially meaningful during tough economic times for the technology sector," said Mark A. Evans, national managing partner of Deloitte's Technology, Media & Telecommunications Group. "We congratulate Cardiac Science on becoming one of the 500 fastest growing technology companies in North America." In addition to ranking on the Deloitte Technology Fast 500, Cardiac Science ranked No. 1 on the Orange County Technology Fast 50, which is a ranking of the 50 fastest growing technology firms in Orange County. Fast 500 Selection and Qualifications The Fast 500 list is compiled from Deloitte's 19 regional North American Fast 50 programs, nominations submitted directly to the Fast 500, and public company database research. To qualify for the Fast 500, entrants must have had 1999 operating revenues of at least $50,000 USD and $75,000 CD for the United States and Canada, respectively; and 2003 operating revenues must be at least $1 million USD or CD. Entrants must also be public or private companies headquartered in North America and must be a "technology company," defined as a company that owns proprietary technology that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology in a unique way does not qualify. About Cardiac Science Cardiac Science develops, manufactures and markets Powerheart(R)-brand public-access defibrillators (AEDs) and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The Company also makes the Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies. For more information, please visit http://www.cardiacscience.com/, email Cardiac Science at or call 1-949-797-3800. About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte," "Deloitte & Touche," "Deloitte Touche Tohmatsu," or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein. Deloitte & Touche USA LLP is the U.S. member firm of Deloitte Touche Tohmatsu. In the U.S., services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Tax LLP, and their subsidiaries), and not by Deloitte & Touche USA LLP. For further information please contact: Matt Clawson (Investors), , or Len Hall (Media), , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Raymond W. Cohen, Chief Executive Officer of Cardiac Science, Inc., +1-949-797-3800, DATASOURCE: Cardiac Science, Inc. CONTACT: Matt Clawson (Investors), , or Len Hall (Media), , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Raymond W. Cohen, Chief Executive Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.cardiacscience.com/

Copyright